Article Details
Retrieved on: 2024-12-22 21:06:18
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses LimmaTech's vaccine candidate for preventing infections by *Staphylococcus aureus*, with a focus on antimicrobial resistance and healthcare-related risks, including for diabetic patients. It highlights the vaccine's FDA fast track status.
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here